Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Naloxonazine is a μ-opioid receptor antagonist (Ki = 0.054 nM in a radioligand binding assay).1 It is selective for μ-opioid over κ- and δ-opioid receptors (Kis = 11 and 8.6 nM, respectively, in radioligand binding assays) and selectively binds to high-affinity µ1-opioid over μ- and δ-opioid receptors (Kds = 0.1, 2, and 5 nM, respectively).1,2 Naloxonazine (0.16 mg/kg) reverses sufentanil-induced antinociception, as well as hypercapnia and hypoxia, markers of respiratory depression, in rats.3 It reduces ethanol self-administration and food intake in rats when administered at a dose of 10 mg/kg.4 Naloxonazine (20 mg/kg) inhibits cocaine-induced place preference in rats.5
WARNING This product is not for human or veterinary use.
1. Pharmacological characterization of the cloned κ-
2. Naloxonazine effects on the interaction of enkephalin analogs with mu-
3. Antagonistic effects of naloxone and naloxonazine on sufentanil-
4. μ1-
5. Effects of the selective μ1-